Related Experiment Videos
[Methionine derivatives with liver protecting activity]
Il Farmaco; Edizione Scientifica
|October 1, 1986
Summary
New methionine derivatives show promise in protecting against liver toxins like carbon tetrachloride and paracetamol. While effective, one compound (MG 28226) exhibited minor toxicity in further studies.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Toxicology
Background:
- Hepatotoxicity is a significant concern, often induced by xenobiotics such as carbon tetrachloride (CCl4) and paracetamol.
- Methionine derivatives are explored for their potential hepatoprotective properties.
Purpose of the Study:
- To synthesize and evaluate novel methionine derivatives for their efficacy in protecting against various chemical-induced liver injuries.
- To identify specific derivatives with significant protective activity and assess their preliminary toxicity profiles.
Main Methods:
- Synthesis of methionine derivatives featuring acylated amine groups with omega-thiol functionalities.
- In vivo testing of synthesized compounds against CCl4, paracetamol, ethyl alcohol, and ethionine intoxication models.
- Subacute toxicity assessment of promising candidates.
Main Results:
- Several synthesized methionine derivatives demonstrated significant protection against tested hepatotoxins.
- Acid (XIV) (MG 28013) and its alkyl derivatives (XVIII) (MG 28228) and (XIX) (MG 28226) exhibited notable hepatoprotective effects.
- Compound MG 28226 showed slight intolerance during subacute toxicity evaluation.
Conclusions:
- The novel methionine derivatives possess promising hepatoprotective potential against a range of toxic insults.
- Further investigation and optimization are warranted, particularly concerning the safety profile of MG 28226.